Endocyte secures $15 million credit facility --August 30, 2010
Endocyte files registration statement with SEC for initial public offering --August 17, 2010
Endocyte announces PRECEDENT interim analysis results --June 05, 2010
Endocyte to present results from four clinical trials at ASCO annual meeting --May 11, 2010
Endocyte announces DSMB supports continuation of phase 2 PRECEDENT study --March 03, 2010
Endocyte awarded patent for vitamin receptor binding drug delivery conjugates --October 27, 2009
Endocyte presents data on EC145 in treatment of ovarian cancer at the 16th annual meeting of the European Society of Gynaecologic Oncology --October 21, 2009
Endocyte announces close of $26 million equity financing --October 15, 2009
Endocyte announces achievement of second milestone in collaboration with Bristol-Myers Squibb --August 26, 2009
Endocyte announces positive results from a Phase II clinical study of EC145 in patients with advanced non-small cell lung cancer (NSCLC) --August 10, 2009
Endocyte to present data on EC145 at the IASLC 13th World Conference on Lung Cancer --July 14, 2009
Endocyte initiates phase 1 trial of EC0489 for treatment of refractory or metastatic solid tumors --May 05, 2009
Endocyte to present multiple abstracts at the 100th annual meeting of the american association for cancer research (AACR) --April 17, 2009
Endocyte announces positive interim results from phase II clinical trial of EC145 in patients with advanced non-small cell lung cancer (NSCLC) --March 24, 2009
Endocyte begins phase II clinical trial of EC145 for treatment of women with ovarian cancer --February 19, 2009
Endocyte to Present at the BIO Investor Forum 2008 --October 13, 2008
Endocyte Receives "Indiana Companies to Watch" Award --September 10, 2008
Endocyte Secures $15 Million Venture Debt Facility --January 25, 2008
Endocyte Announces Achievement of Milestone in Collaboration with Bristol-Myers Squibb --January 04, 2008
Endocyte to Present at the 26th Annual JPMorgan Healthcare Conference --January 03, 2008
Endocyte Announces License Agreement with R&D Biopharmaceuticals for the Development of Targeted Tubulysin Chemotherapeutic Agents --December 21, 2007
Chandra Lovejoy joins Endocyte as Director of Regulatory Affairs --December 17, 2007
Endocyte secures $15 million in Series C-3 round of financing --March 23, 2007
Endocyte awarded patent for vitamin-targeted imaging agent --November 29, 2006
Purdue honors faculty entrepreneurs for life-altering inventions --October 11, 2006
Michael A. Sherman Joins Endocyte as CFO --October 09, 2006
Keith E. Brauer Joins the Endocyte Board of Directors --September 12, 2006
Endocyte Announces Patent Issued to Enhance Cancer Targeting in Immunotherapy --May 16, 2006
Endocyte begins Phase 1 trial of EC145 for treatment of refractory solid tumors --April 20, 2006
Endocyte Signs Agreement with Bristol-Myers Squibb to Develop and Commercialize Folate-Targeted Chemotherapeutic Agents --January 05, 2006
Endocyte Receives Notice of a U.S. Patent Allowance for a Targeted Immunotherapy Treatment --November 02, 2005
Richard Messmann join’s Endocyte’s executive management team --July 13, 2005
Purdue anchors Indy's newest technology park, 3 companies move in --April 26, 2005
Emory Researchers Awarded $1.6 Million to Study Common Type of Pituitary Tumor --March 30, 2005
Endocyte secures close to $23 million in Series C-2 round of financing --December 06, 2004
Endocyte's research to reduce chemo's side effects receives state-federal dollars --November 15, 2004
WL research 'triangle' sprouting walls, jobs --August 15, 2004
Endocyte Inc. named a finalist for an Indiana Ernst & Young Entrepreneur of the Year 2004 Award --May 10, 2004
Purdue Research Park to add 60,000 square feet of incubator space --April 01, 2004
Endocyte, Inc. honored with 2003 Indiana Growth 100 Award --November 19, 2003
Endocyte Signs Clinical Trials Agreement with the National Cancer Institute for its FolateScan Product --October 16, 2003
August Watanabe, M.D. joins board of directors at Endocyte --September 05, 2003
Endocyte secures $15 million in Series C round of financing --August 15, 2003
Endocyte begins first clinical trial with new metastatic cancer treatment --May 09, 2003
Endocyte Selects eResearch Technology eResearch Network to Deliver Comprehensive Infrastructure --May 06, 2003
New director of clinical operations joins Endocyte team --January 31, 2003
Endocyte enters third round of financing --October 01, 2002
Researchers developing technology to outsmart metastasized cancers --June 19, 2002
Endocyte signs license agreement with Galenica --May 14, 2002
Endocyte signs licensing agreement for Sangstat's Complexine Technology --October 01, 2001
Endocyte Inc. secures $7.6 million in equity investments --July 10, 2001
Cancer research firm among companies to benefit from grants --February 22, 2001
Endocyte, Inc. and National Cancer Institute announce agreement to develop vitamin based anticancer agents --March 01, 1999
Top
